As the year draws to a close, medium and small drugmakers in India have a deadline coming up in less than two months as the country moves to secure the production of safe and quality medicines. After ...
Notified in December 2023, the revised Schedule M has shifted the focus from “good manufacturing practices” to “good ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback